2022
DOI: 10.3389/fneur.2022.1003046
|View full text |Cite
|
Sign up to set email alerts
|

Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series

Abstract: BackgroundWe present the disease course and long-term follow-up of two patients who were phenotypically diagnosed with atypical Leber Hereditary Optic Neuropathy (LHON) 14 and 12 years ago, respectively, whereby whole exome sequencing revealed recently described recessive DNAJC30:c.152G>A 152 A>G (p.Tyr51Cys) homozygous pathogenic variant with significant spontaneous visual acuity recovery in one.Case presentationTwo presented unrelated males with atypical LHON with sequential visual acuity (VA) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 12 publications
(16 reference statements)
0
4
0
Order By: Relevance
“… 18 , 19 Importantly, arLHON patients carrying DNAJC30 mutations displayed a significantly higher ratio of visual improvement (up to 81%) after idebenone treatment ( Table 3 ). In contrast, DNAJC30 patients who received corticoid boluses during the acute phase of the disease instead of idebenone showed no visual acuity recovery, 4 , 9 ,10 as did the patient carrying MCAT variants. 6 However, a gain of visual acuity upon corticoid treatment has been reported occasionally (one individual with a DNAJC30 mutation 4 and two of three siblings carrying NDUFS2 mutations 3 ; Table 3 ).…”
Section: Introductionmentioning
confidence: 83%
See 1 more Smart Citation
“… 18 , 19 Importantly, arLHON patients carrying DNAJC30 mutations displayed a significantly higher ratio of visual improvement (up to 81%) after idebenone treatment ( Table 3 ). In contrast, DNAJC30 patients who received corticoid boluses during the acute phase of the disease instead of idebenone showed no visual acuity recovery, 4 , 9 ,10 as did the patient carrying MCAT variants. 6 However, a gain of visual acuity upon corticoid treatment has been reported occasionally (one individual with a DNAJC30 mutation 4 and two of three siblings carrying NDUFS2 mutations 3 ; Table 3 ).…”
Section: Introductionmentioning
confidence: 83%
“… Based on steroid/corticosteroid treatment documented in 12 individuals showing no improvement in 11/12 individuals (10 and 1 carrying the p.Tyr51Cys and p.Leu101Gln mutations in homozygosity, respectively). 4 , 9 , 10 Visual improvement is noted in 1/12 individual carrying the p.Pro78Ser mutation in homozygosity. 4 …”
Section: Introductionmentioning
confidence: 97%
“…The changes in RGCs and in the retinal nerve fiber layer (RNFL) strongly impact the central retina leading to low vision or irreversible legal blindness with small number of patients that eventually recover vision partially [ 7 , 8 ]. Equivalent mitochondrial alterations can be also caused by biallelic mutations in genes of the nuclear DNA leading to an autosomal recessive form of LHON, as recently reported [ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 87%
“…14 In contrast to LHON caused by mtDNA mutations, arLHON tends to have an earlier disease onset age, such as 12 or 14, and a higher rate of visual recovery. 15…”
Section: Dnajc30mentioning
confidence: 99%